LONDON AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project.
PUNE Serum Institute of India, which has partnered with AstraZeneca to manufacture its COVID-19 vaccine, will continue to test a two full dose regimen of the shot despite it showing a lower success rate than a half and full dose regimen in pivotal trials, a top executive told Reuters.
MUMBAI/NEW DELHI Jeff Bezos and Mukesh Ambani, two of the world's richest men, face a turning point in a battle for preeminence in India's booming, nearly trillion-dollar retail market.
NEW DELHI/MUMBAI India's National Stock Exchange (NSE) privately warned Future Retail it risked regulatory action for not making timely market disclosures about efforts by Amazon.com to block a disputed asset sale, according to e-mails reviewed by Reuters.
MUMBAI The head of an Indian company contracted to make AstraZeneca Plc's COVID vaccine said it could deliver it to health care workers and elderly Indians by January as the country's caseload of infections crossed nine million on Friday.